Home Trials Genes Drugs 23andMe Graph Blog Contact

Home
Trials
Genes
Drugs
23andMe
Graph
Blog
Contact

Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

ClinicalTrials.gov
OpenTargets
ClinVar
PubChem

Post Market Clinical Follow-up of EUROSCUP Fixe Acetabular Cup

N/AActive Not RecruitingNCT05142462

EUROS120 enrolled

Overview

EUROSCUP Fixe is intended for use in primary and revision total hip replacement surgery. Hip replacement is intended to provide increased patient mobility and reduce pain by replacing the damages hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components. As part of post market vigilance, EUROS will collect data on EUROSCUP Fixe performances and safety

Post market observational study. This study is retropective and prospective, non comparative.

Study Type

OBSERVATIONAL

Enrollment

120

Conditions

Hip Arthropathy Hip Osteoarthritis Hip Necrosis Hip Fractures Hip Dysplasia Hip Arthritis

Interventions

Hip arthroplasty

DEVICE

Hip prosthesis surgical implantation

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patient who received EUROSCUP Fixe. * Patient informed of its participation to the study * Patient aged between 18 and 80 years old (\<80). Exclusion Criteria: * Patient presenting a contraindication to EUROSCUP Fixe implantation. * Patient who refused to participate to the study * Vulnerable subjects

Locations (4)

Clinique Esquirol Saint Hilaire

Agen, France

Clinique de L'Atlantique

Puilboreau, France

Centre Hospitalier SECLIN

Seclin, France

Clinique St Roch

Toulon, France

Outcomes

Primary Outcomes

Safety of EUROSCUP Fixe

Collect the safety of the device trought complications occurence rate

Time frame: 1 year

Secondary Outcomes

Clinical performances of EUROSCUP Fixe

Collect the performances of the device trought clinical scores

Time frame: 1 year

Radiological performances of EUROSCUP Fixe

Collect the performances of the device trought radiological evaluation

Time frame: 1 year

Survival of EUROSCUP Fixe

Assess the survival rate of the device

Time frame: 10 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.